Mr. Speaker, I would like to thank the hon. member for her question. First of all, let me reassure Canadians by saying that the inspections carried out by the FDA were the result of a change in its own policies and were not brought about by problems in the way the blood supply is handled in Canada. It is a question of harmonizing various policies, since the regulations differ. We are working with the FDA and will continue to do so in order to achieve harmonization. Our blood system in Canada is as safe as any in the world.
In the House of Commons on September 19th, 1994. See this statement in context.